By Norma Erickson, SaneVax Inc. May 2016: AutismOne hosted the first International HPV Vaccine Safety Symposium in Chicago, Illinois. For perhaps the first time in history, people from around the globe came together to discuss their experiences with a single type of vaccine. Multiple presentations made it abundantly clear to all that HPV vaccines embody […]
EMA response to questions regarding HPV vaccine safety assessment
[Note from SaneVax: On April 23 an open letter was sent to the European Medicines Authority (EMA) containing multiple questions regarding their recent assessment of HPV vaccine safety. True to their word, the EMA responded within 30 days. Their response was sent to signatories for perusal. Below is the original letter, complete with the EMA responses […]
European Medicines Agency Under Investigation
[SaneVax: People around the world are beginning to question the workings of government health agencies. Those agencies responsible for the health and well-being of the people who pay their salaries are apparently not looking out for the best interests of their constituents. In many cases, it appears regulatory agencies put the pharmaceutical companies’ agenda above safety […]
Freda Birrell, SANE Vax, letter to Committee for Medicinal Products for Human Use regarding Gardasil contamination
Dear Mr Chairman and Vice-Chairman of the CHMP Committee I am sending the undernoted to all the members of your Committee The two Press Releases, the one attached above “Sane Vax Inc announces the discovery of Viral HPV DNA Contaminant in Gardasil and the following link to “Sane Vax Inc discovers potential biohazard contamination in Merck’s Gardasil HPV […]
Gardasil Contamination: EMA Steps Up to the Plate, FDA drops the Ball
By Norma Erickson, President 16 September 2011, in response to an inquiry about SANE Vax’s recent discovery of genetically engineered HPV DNA in Gardasil™[i], the following announcement was broadcast on Tipp.fm radio out of Clonmel, County Tipperary, Ireland: “The IMB (Irish Medicines Board) and European Medicines Agency (EMA) are aware of the recent communication from […]
